Affiliation:
1. Division of Hematology, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
2. Research and Development, Pfizer Global Biologics, Chesterfield, Missouri 63017
Abstract
ABSTRACT
Toll-like receptor (TLR)-expressing cells, for the first time, detected and identified a microbial contaminant in a product made in
Escherichia coli
using an old manufacturing process. It was suspected of having a microbial contaminant(s) because, although it tested negative by standard pyrogen assays, it was associated with adverse events in early clinical trials. The assay readout is the induction of NF-κB and/or cytokines in response to TLR activation. Four coded samples, labeled A to D, including a sample prepared by the older manufacturing process, were submitted. The cell lines were activated only by samples B and D. Sample D stimulated only Mono-Mac 6 and HEK-human TLR4 (hTLR4) cells and was later identified as lipopolysaccharide. Except for TLR3 cells, sample B stimulated cells bearing the different TLRs (TLRs 2, 4, 5, 7, 8, and 9) and nontransfected HEK293 cells. These data suggested that flagellin was the microbial contaminant, since TLR5, the receptor for flagellin, is known to be expressed constitutively on HEK293 cells. Moreover, purified flagellin from
Salmonella enterica
serovar Typhimurium behaved like sample B, stimulating HEK293 and HEK-hTLR5 cells but not HEK-hTLR3 cells, and this stimulation by flagellin and sample B was blocked by an anti-hTLR5 neutralizing antibody. Western blots showed bands positive for flagellin and sample B with the molecular sizes expected for the flagellins from
S
. Typhimurium and
E. coli
, respectively. Mass spectrometry data were consistent with the presence of flagellin in the manufacturer's sample B. Taken together, these data indicate that the microbial contaminant in sample B was flagellin and may have been associated with adverse events when the recombinant product was administered.
Publisher
American Society for Microbiology
Reference28 articles.
1. Pathogen Recognition and Innate Immunity
2. Current good manufacturing practice for finished pharmaceuticals: special testing requirements. 2009
3. General biological products standards: purity. 2009
4. DHHS. 2008. Availability of the ICCVAM test method evaluation report and final background review document, and transmittal of ICCVAM test method recommendations to federal agencies. Fed. Regist.73:71003-71004.
5. Feng, P., R. J. Sugasawara, and A. Schantz. 1990. Identification of a common enterobacterial flagellin epitope with a monoclonal antibody. J. Gen. Microbiol.136:337-342.
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献